Literature DB >> 2556842

The primary structure of major viral RNA in a rat cell line transfected with type 47 human papillomavirus DNA and the transforming activity of its cDNA and E6 gene.

T Kiyono1, K Nagashima, M Ishibashi.   

Abstract

A transformed cell line (RC335) showing higher saturation cell density was obtained from 3Y1 cells (a fibroblastic cell line of rat) transfected with DNA of human papillomavirus type 47 (HPV-47), an epidermodysplasia verruciformis-associated virus, which our laboratory reported previously. The cell line was found to produce a major and several minor species of viral RNAs. The primary structure of the major viral RNA in RC335 was extensively studied and found to consist of two exons and contain open reading frames (ORFs) E6, E7, and a fused ORF, E1/E4. The major RNA was indicated to play an important role in the transformation of RC335 by an experiment with the recombinant retrovirus designed to produce the RNA containing these ORFs, i.e., the recombinant virus induced transformation similar to that in RC335 upon infection of 3Y1 cells. Furthermore the experiments with recombinant viruses carrying a nonsense mutation or large deletion in the above ORF(s) indicated that E6 was necessary and sufficient for the transformation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2556842     DOI: 10.1016/0042-6822(89)90567-9

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  In vitro expressed HPV 8 E6 protein does not bind p53.

Authors:  G Steger; H Pfister
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Inhibition of p53-mediated transactivation by E6 of type 1, but not type 5, 8, or 47, human papillomavirus of cutaneous origin.

Authors:  T Kiyono; A Hiraiwa; S Ishii; T Takahashi; M Ishibashi
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

Review 3.  Human papillomavirus and the development of non-melanoma skin cancer.

Authors:  C A Harwood; J M McGregor; C M Proby; J Breuer
Journal:  J Clin Pathol       Date:  1999-04       Impact factor: 3.411

4.  Mapping of betapapillomavirus human papillomavirus 5 transcription and characterization of viral-genome replication function.

Authors:  Eve Sankovski; Andres Männik; Jelizaveta Geimanen; Ene Ustav; Mart Ustav
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

5.  Detection of human papillomavirus (HPV) type 47 DNA in malignant lesions from epidermodysplasia verruciformis by protocols for precise typing of related HPV DNAs.

Authors:  A Adachi; T Kiyono; Y Hayashi; M Ohashi; M Ishibashi
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

6.  Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1.

Authors:  A Schmitt; J B Harry; B Rapp; F O Wettstein; T Iftner
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

7.  Late promoter of human papillomavirus type 8 and its regulation.

Authors:  F Stubenrauch; J Malejczyk; P G Fuchs; H Pfister
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

8.  The transcription map of human papillomavirus type 18 during genome replication in U2OS cells.

Authors:  Mart Toots; Andres Männik; Gaily Kivi; Mart Ustav; Ene Ustav; Mart Ustav
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

9.  Tumorigenic transformation of primary rat embryonal fibroblasts by human papillomavirus type 8 E7 gene in collaboration with the activated H-ras gene.

Authors:  T Nishikawa; T Yamashita; T Yamada; H Kobayashi; A Ohkawara; K Fujinaga
Journal:  Jpn J Cancer Res       Date:  1991-12

10.  High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in "Stripped" biopsies from the same tumors.

Authors:  Ola Forslund; Bernt Lindelöf; Eva Hradil; Peter Nordin; Bo Stenquist; Reinhard Kirnbauer; Katharina Slupetzky; Joakim Dillner
Journal:  J Invest Dermatol       Date:  2004-08       Impact factor: 8.551

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.